Evidence map›Paper›PMID 36607642›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2023

DUOX2 regulates secreted factors in virus-infected respiratory epithelial cells that contribute to neutrophil attraction and activation.

Dacquin M Kasumba, Sandrine Huot, Elise Caron, Audray Fortin, Cynthia Laflamme, Natalia Zamorano Cuervo, Felix Lamontagne, Marc Pouliot, Nathalie Grandvaux

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. DUOX2 regulates secreted factors in virus-infected respiratory epithelial cells that contribute to neutrophil attraction and activation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Dacquin M KasumbaCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Sandrine HuotDépartement de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
Elise CaronCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Audray FortinCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Cynthia LaflammeAxe maladies infectieuses et immunitaires, Centre de Recherche du CHU de Québec - Université Laval, Québec City, Québec, Canada.
Natalia Zamorano CuervoCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Felix LamontagneCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Marc PouliotDépartement de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine de l'Université Laval, Centre de Recherche du CHU de Québec-Université Laval, Québec City, Québec, Canada.ORCID https://orcid.org/0000-0002-2466-5424
Nathalie GrandvauxCentre de recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.ORCID https://orcid.org/0000-0003-0567-0284
Centre Hospitalier de l’Université de Montréal · CAUniversité Laval · CA

Funding

CIHR MOP-137099
6 · The paper itself

Abstract

The first line of defense against respiratory viruses relies on the antiviral and proinflammatory cytokine response initiated in infected respiratory epithelial cells. The cytokine response not only restricts virus replication and spreading, but also orchestrates the subsequent immune response. The epithelial Dual Oxidase 2 (DUOX2) has recently emerged as a regulator of the interferon antiviral response. Here, we investigated the role of DUOX2 in the inflammatory cytokine response using a model of A549 cells deficient in DUOX2 generated using Crispr-Cas9 and infected by Sendai virus. We found that the absence of DUOX2 selectively reduced the induction of a restricted panel of 14 cytokines and chemokines secreted in response to Sendai virus by 20 to 89%. The secreted factors produced by epithelial cells upon virus infection promoted the migration, adhesion, and degranulation of primary human neutrophils, in part through the DUOX2-dependent secretion of TNF and chemokines. In contrast, DUOX2 expression did not impact neutrophil viability or NETosis, thereby highlighting a selective impact of DUOX2 in neutrophil functions. Overall, this study unveils previously unrecognized roles of epithelial DUOX2 in the epithelial-immune cells crosstalk during respiratory virus infection.

Indexed as

NeutrophilsVirusesAntiviral AgentsChemokinesCytokinesDual OxidasesEpithelial CellsHumansAntiviral AgentsChemokinesCytokinesDual OxidasesDUOX2 protein, humanantiviralcytokinesDUOX2epithelial cellsinflammationneutrophilsredoxrespiratoryvirus

Identifiers

PMID36607642
PMCPMC10107641
OpenAlexW4313650198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.